There are different types of products available in the interventional radiology market, including
magnetic resonance imaging (MRI), ultrasound, computed tomography (CT),
angiography systems, and others. The market for ultrasound systems is estimated
to progress substantially during the forecast period, registering a CAGR of
6.2%. The reason for such growth would be the increasing prevalence of birth
disorders and chronic diseases that are boosting the demand for ultrasound
systems globally.
Furthermore, the domain, on the basis of application, is
categorized into cardiology, oncology, gastroenterology, urology and
nephrology, obstetrics and gynecology, and others. Out of these, oncology is
estimated to contribute the most significant share
to the interventional radiology market in the forecast period. The
oncology segment is expected to generate $5.1 billion revenue for the market in
2018 and $7.3 billion by 2024. Across the globe, the increasing prevalence of
cancer has boosted this segment. Furthermore, the market for gastroenterology
is also expected to experience significant growth, progressing at a CAGR of5.9% during the analysis period.
Across the globe, the interventional radiology market is
registering growth owing to a substantial number of new equipment being
introduced by prominent players. For instance, Canon Medical Systems
Corporation, within its Vitrea platform, launched the illumination rendering
technology in January 2019. This will enable real-time interaction with
photorealistic images, allowing physicians to visualize patient’s anatomy in
all dimensions. That same year, Canon also launched the Aquilian Start CT
system in Dubai.
